BTK and brain ischemia: For example, Ito et al. (2015) showed that using ibrutinib to inhibit Bruton’s tyrosine kinase (BTK), an essential component of the NLRP3 inflammasome, reduced infarct volume, and neurological damage in a mouse model of cerebral ischemia/reperfusion injury.